Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Change in Receivables (2016 - 2025)

Historic Change in Receivables for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to -$21000.0.

  • ProPhase Labs' Change in Receivables rose 9860.19% to -$21000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $93000.0, marking a year-over-year increase of 10141.19%. This contributed to the annual value of -$4.7 million for FY2024, which is 86790.92% down from last year.
  • Latest data reveals that ProPhase Labs reported Change in Receivables of -$21000.0 as of Q3 2025, which was up 9860.19% from -$118000.0 recorded in Q2 2025.
  • Over the past 5 years, ProPhase Labs' Change in Receivables peaked at $30.9 million during Q4 2021, and registered a low of -$7.7 million during Q2 2021.
  • Moreover, its 5-year median value for Change in Receivables was $146000.0 (2025), whereas its average is $2.0 million.
  • The largest annual percentage gain for ProPhase Labs' Change in Receivables in the last 5 years was 2541239.67% (2021), contrasted with its biggest fall of 117559.27% (2021).
  • ProPhase Labs' Change in Receivables (Quarter) stood at $30.9 million in 2021, then plummeted by 94.02% to $1.8 million in 2022, then crashed by 195.5% to -$1.8 million in 2023, then skyrocketed by 104.88% to $86000.0 in 2024, then plummeted by 124.42% to -$21000.0 in 2025.
  • Its last three reported values are -$21000.0 in Q3 2025, -$118000.0 for Q2 2025, and $146000.0 during Q1 2025.